Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute interstitial nephritis related to immune checkpoint inhibitors.
Belliere J, Meyer N, Mazieres J, Ollier S, Boulinguez S, Delas A, Ribes D, Faguer S. Belliere J, et al. Among authors: boulinguez s. Br J Cancer. 2016 Dec 6;115(12):1457-1461. doi: 10.1038/bjc.2016.358. Epub 2016 Nov 10. Br J Cancer. 2016. PMID: 27832664 Free PMC article.
Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.
Masson Regnault M, Ofaiche J, Boulinguez S, Tournier E, Rochaix P, Paul C, Lamant L, Meyer N. Masson Regnault M, et al. Among authors: boulinguez s. J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e73-e74. doi: 10.1111/jdv.13733. Epub 2016 Jun 3. J Eur Acad Dermatol Venereol. 2017. PMID: 27256718 No abstract available.
[Dermatologic toxicities of immune checkpoint inhibitors].
Sibaud V, Boulinguez S, Pagès C, Riffaud L, Lamant L, Chira C, Boyrie S, Vigarios E, Tournier E, Meyer N. Sibaud V, et al. Among authors: boulinguez s. Ann Dermatol Venereol. 2018 May;145(5):313-330. doi: 10.1016/j.annder.2018.01.047. Epub 2018 Apr 18. Ann Dermatol Venereol. 2018. PMID: 29678394 Review. French.
BRAF V600 inhibitor discontinuation after complete response in advanced melanoma: a retrospective analysis of 16 patients.
Vanhaecke C, Deilhes F, Chanal J, Regnier-Rosencher E, Boitier F, Boulinguez S, Avril MF, Guégan S, Dupin N, Aractingi S, Meyer N, Kramkimel N. Vanhaecke C, et al. Among authors: boulinguez s. Br J Dermatol. 2017 Oct;177(4):e94-e95. doi: 10.1111/bjd.15345. Epub 2017 Aug 30. Br J Dermatol. 2017. PMID: 28129668 No abstract available.
Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab.
Fradet M, Sibaud V, Tournier E, Lamant L, Boulinguez S, Brun A, Pages C, Meyer N. Fradet M, et al. Among authors: boulinguez s. Acta Derm Venereol. 2019 Dec 1;99(13):1301-1302. doi: 10.2340/00015555-3301. Acta Derm Venereol. 2019. PMID: 31449315 Free article. No abstract available.
105 results